Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Midkine translocated to nucleoli and involved in carcinogenesis Dai LCWorld J Gastroenterol 2009[Jan]; 15 (4): 412-6Midkine (MK) is a heparin-binding growth factor with its gene first identified in embryonal carcinoma cells at early stages of retinoic acid-induced differentiation. MK is frequently and highly expressed in a variety of human carcinomas. Furthermore, the blood MK level is frequently elevated with advance of human carcinomas, decreased after surgical removal of the tumors. Thus, it is expected to become a promising marker for evaluating the progress of carcinomas. There is mounting evidence that MK plays a significant role in carcinogenesis-related activities, such as proliferation, migration, anti-apoptosis, mitogenesis, transforming, and angiogenesis. In addition, siRNA and anti-sense oligonucleotides for MK have yielded great effects in anti-tumor activities. Therefore, MK appears to be a potential candidate molecular target of therapy for human carcinomas. In this paper, we review MK targeting at nucleoli in different tumor cells and its role in carcinogenesis to deepen our understanding of the mechanism of MK involved in carcinogenesis.|Active Transport, Cell Nucleus[MESH]|Animals[MESH]|Cell Line, Tumor[MESH]|Cell Nucleolus/*metabolism[MESH]|Cytokines/antagonists & inhibitors/genetics/*metabolism[MESH]|Genetic Therapy[MESH]|Humans[MESH]|LDL-Receptor Related Proteins/metabolism[MESH]|Midkine[MESH]|Models, Biological[MESH]|Neoplasms/*etiology/metabolism/therapy[MESH]|Oligodeoxyribonucleotides, Antisense/genetics/therapeutic use[MESH]|Proteasome Endopeptidase Complex/metabolism[MESH]|Recombinant Fusion Proteins/genetics/metabolism[MESH] |